132 related articles for article (PubMed ID: 28453728)
1. Cardiac mGluR1 metabotropic receptors in cardioprotection.
Vincent A; Sportouch C; Covinhes A; Barrère C; Gallot L; Delgado-Betancourt V; Lattuca B; Solecki K; Boisguérin P; Piot C; Nargeot J; Barrère-Lemaire S
Cardiovasc Res; 2017 May; 113(6):644-655. PubMed ID: 28453728
[TBL] [Abstract][Full Text] [Related]
2. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
Kaur K; Singh N; Dhawan RK
Eur J Pharmacol; 2020 Sep; 883():173231. PubMed ID: 32589885
[TBL] [Abstract][Full Text] [Related]
3. MG53 participates in ischaemic postconditioning through the RISK signalling pathway.
Zhang Y; Lv F; Jin L; Peng W; Song R; Ma J; Cao CM; Xiao RP
Cardiovasc Res; 2011 Jul; 91(1):108-15. PubMed ID: 21285295
[TBL] [Abstract][Full Text] [Related]
4. Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.
Lacerda L; Somers S; Opie LH; Lecour S
Cardiovasc Res; 2009 Nov; 84(2):201-8. PubMed ID: 19666677
[TBL] [Abstract][Full Text] [Related]
5. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
[TBL] [Abstract][Full Text] [Related]
6. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
Ha T; Hu Y; Liu L; Lu C; McMullen JR; Kelley J; Kao RL; Williams DL; Gao X; Li C
Cardiovasc Res; 2010 Sep; 87(4):694-703. PubMed ID: 20421349
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 (GLP-1) mediates cardioprotection by remote ischaemic conditioning.
Basalay MV; Mastitskaya S; Mrochek A; Ackland GL; Del Arroyo AG; Sanchez J; Sjoquist PO; Pernow J; Gourine AV; Gourine A
Cardiovasc Res; 2016 Dec; 112(3):669-676. PubMed ID: 27702763
[TBL] [Abstract][Full Text] [Related]
8. Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
Strande JL; Widlansky ME; Tsopanoglou NE; Su J; Wang J; Hsu A; Routhu KV; Baker JE
Cardiovasc Res; 2009 Jul; 83(2):325-34. PubMed ID: 19380418
[TBL] [Abstract][Full Text] [Related]
9. Stat5-dependent cardioprotection in late remote ischaemia preconditioning.
Chen H; Jing XY; Shen YJ; Wang TL; Ou C; Lu SF; Cai Y; Li Q; Chen X; Ding YJ; Yu XC; Zhu BM
Cardiovasc Res; 2018 Apr; 114(5):679-689. PubMed ID: 29365089
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A₂A and A₂B receptors are both required for adenosine A₁ receptor-mediated cardioprotection.
Zhan E; McIntosh VJ; Lasley RD
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H1183-9. PubMed ID: 21743001
[TBL] [Abstract][Full Text] [Related]
11. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y
Audia JP; Yang XM; Crockett ES; Housley N; Haq EU; O'Donnell K; Cohen MV; Downey JM; Alvarez DF
Basic Res Cardiol; 2018 Jul; 113(5):32. PubMed ID: 29992382
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
Obana M; Miyamoto K; Murasawa S; Iwakura T; Hayama A; Yamashita T; Shiragaki M; Kumagai S; Miyawaki A; Takewaki K; Matsumiya G; Maeda M; Yoshiyama M; Nakayama H; Fujio Y
Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H569-77. PubMed ID: 22707562
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
14. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the muscle-specific protein, melusin, protects from cardiac ischemia/reperfusion injury.
Penna C; Brancaccio M; Tullio F; Rubinetto C; Perrelli MG; Angotti C; Pagliaro P; Tarone G
Basic Res Cardiol; 2014 Jul; 109(4):418. PubMed ID: 24859929
[TBL] [Abstract][Full Text] [Related]
16. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
17. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
[TBL] [Abstract][Full Text] [Related]
18. Vagal stimulation mimics preconditioning and postconditioning of ischemic myocardium in mice by activating different protection mechanisms.
Buchholz B; Kelly J; Muñoz M; Bernatené EA; Méndez Diodati N; González Maglio DH; Dominici FP; Gelpi RJ
Am J Physiol Heart Circ Physiol; 2018 Jun; 314(6):H1289-H1297. PubMed ID: 29631370
[TBL] [Abstract][Full Text] [Related]
19. Catalpol decreases peroxynitrite formation and consequently exerts cardioprotective effects against ischemia/reperfusion insult.
Huang C; Cui Y; Ji L; Zhang W; Li R; Ma L; Xing W; Zhou H; Chen B; Yu J; Zhang H
Pharm Biol; 2013 Apr; 51(4):463-73. PubMed ID: 23336403
[TBL] [Abstract][Full Text] [Related]
20. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
